Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Item 9 Labs (INLB) Receivables (2018 - 2023)

Item 9 Labs' Receivables history spans 12 years, with the latest figure at $5.8 million for Q2 2023.

  • For Q2 2023, Receivables fell 37.32% year-over-year to $5.8 million; the TTM value through Jun 2023 reached $5.8 million, down 37.32%, while the annual FY2022 figure was $8.3 million, 56.73% down from the prior year.
  • Receivables reached $5.8 million in Q2 2023 per INLB's latest filing, up from $5.4 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $19.2 million in Q3 2021 to a low of $80000.0 in Q4 2020.
  • Average Receivables over 5 years is $5.3 million, with a median of $2.9 million recorded in 2019.
  • Peak YoY movement for Receivables: crashed 83.15% in 2020, then soared 17973.54% in 2021.
  • A 5-year view of Receivables shows it stood at $474715.0 in 2019, then plummeted by 83.15% to $80000.0 in 2020, then skyrocketed by 17973.54% to $14.5 million in 2021, then tumbled by 42.46% to $8.3 million in 2022, then plummeted by 30.85% to $5.8 million in 2023.
  • Per Business Quant, the three most recent readings for INLB's Receivables are $5.8 million (Q2 2023), $5.4 million (Q1 2023), and $8.3 million (Q4 2022).